|
1
|
Cooper SL and Brown PA: Treatment of
pediatric acute lymphoblastic leukemia. Pediatr Clin North Am.
62:61–73. 2015. View Article : Google Scholar :
|
|
2
|
Lussana F and Rambaldi A: Role of
allogeneic hematopoietic stem cell transplantation in adult
patients with acute lymphoblastic leukemia. Mediterr J Hematol
Infect Dis. 6:e20140652014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
te Boekhorst PA, de Leeuw K, Schoester M,
Wittebol S, Nooter K, Hagemeijer A, Löwenberg B and Sonneveld P:
Predominance of functional multidrug resistance (MDR-1) phenotype
in CD34+ acute myeloid leukemia cells. Blood.
82:3157–3162. 1993.PubMed/NCBI
|
|
4
|
Zhang BB, Xuan C, Deng KF, Wu N and Lun
LM: Association between the MDR1 gene variant C3435T and risk of
leukaemia: A meta-analysis. Eur J Cancer Care. 22:617–625. 2013.
View Article : Google Scholar
|
|
5
|
Lage H: An overview of cancer multidrug
resistance: A still unsolved problem. Cell Mol Life Sci.
65:3145–3167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saneja A, Khare V, Alam N, Dubey RD and
Gupta PN: Advances in P-glycoprotein-based approaches for
delivering anticancer drugs: Pharmacokinetic perspective and
clinical relevance. Expert Opin Drug Deliv. 11:121–138. 2014.
View Article : Google Scholar
|
|
7
|
Gillet JP, Efferth T and Remacle J:
Chemotherapy-induced resistance by ATP-binding cassette transporter
genes. Biochim Biophys Acta. 1775:237–262. 2007.PubMed/NCBI
|
|
8
|
Shi Z, Tiwari AK, Shukla S, Robey RW, Kim
IW, Parmar S, Bates SE, Si QS, Goldblatt CS, Abraham I, et al:
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine
kinase inhibitor AG1478. Biochem Pharmacol. 77:781–793. 2009.
View Article : Google Scholar
|
|
9
|
Du BX, Song ZM, Wang K, Zhang H, Xu FY,
Zou Z and Shi XY: Butorphanol prevents morphine-induced pruritus
without increasing pain and other side effects: A systematic review
of randomized controlled trials. Can J Anaesth. 60:907–917. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Parikh GP, Veena SR, Vora K, Parikh B and
Joshi A: Comparison of epidural butorphanol versus epidural
morphine in postoperative pain relief. Middle East J Anaesthesiol.
22:371–376. 2014.PubMed/NCBI
|
|
11
|
Shah B, Raichandani Y and Misra A:
Development and evaluation of oral osmotic pump of butorphanol
tartrate. Pharm Dev Technol. 19:868–880. 2014. View Article : Google Scholar
|
|
12
|
Guo HQ, Zhang GN, Wang YJ, Zhang YK,
Sodani K, Talele TT, Ashby CR Jr and Chen ZS: β-elemene, a compound
derived from Rhizoma zedoariae, reverses multidrug resistance
mediated by the ABCB1 transporter. Oncol Rep. 31:858–866. 2014.
|
|
13
|
Xie X, Yin J, Jia Q, Wang J, Zou C, Brewer
KJ, Colombo C, Wang Y, Huang G and Shen J: Quercetin induces
apoptosis in the methotrexate-resistant osteosarcoma cell line
U2-OS/MTX300 via mitochondrial dysfunction and dephosphorylation of
Akt. Oncol Rep. 26:687–693. 2011.PubMed/NCBI
|
|
14
|
Bonelli MA, Fumarola C, Alferi RR, La
monica S, Cavazzoni A, Galetti M, Gatti R, Belletti S, Harris AL,
Fox SB, et al: Synergistic activity of letrozole and sorafenib on
breast cancer cells. Breast Cancer Res Treat. 124:79–88. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao T, Song Y, Liu B, Qiu Q, Jiao L, Li
Y, Huang W and Qian H: Reversal of P-glycoprotein-medicated
multidrug resistance by LBM-A5 in vitro and a study of its
pharmacokinetics in vivo. Can J Physiol Pharmacol. 93:33–38. 2015.
View Article : Google Scholar
|
|
16
|
Zhou WJ, Zhang X, Cheng C, Wang F, Wang
XK, Liang YJ, To KK, Zhou W, Huang HB and Fu LW: Crizotinib
(PF-02341066) reverses multidrug resistance in cancer cells by
inhibiting the function of P-glycoprotein. Br J Pharmacol.
166:1669–1683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu LW, Zhang YM, Liang YJ, Yang XP and Pan
QC: The multidrug resistance of tumour cells was reversed by
tetrandrine in vitro and in xenografts derived from human breast
adenocarcinoma MCF-7/adr cells. Eur J Cancer. 38:418–426. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim SK, Jung WH and Koo JS: Differential
expression of enzymes associated with serine/glycine metabolism in
different breast cancer subtypes. PLoS One. 9:e1010042014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Samuel S, Beljanski V, Van Grevenynghe J,
Richards S, Ben Yebdri F, He Z, Nichols C, Belgnaoui SM, Steel C,
Goulet ML, et al: BCL-2 inhibitors sensitize therapy-resistant
chronic lymphocytic leukemia cells to VSV oncolysis. Mol Ther.
21:1413–1423. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aggarwal H, Aggarwal A, Hunter WJ III,
Yohannes P, Khan AU and Agrawal DK: Expression of leukemia/lymphoma
related factor (LRF/Pokemon) in human benign prostate hyperplasia
and prostate cancer. Exp Mol Pathol. 90:226–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Duan S, Chu C, Xu J, Zeng G, Lam AK,
Zhou J, Yin Y, Fang D, Reynolds MJ, et al: Melaleuca alternifolia
concentrate inhibits in vitro entry of influenza virus into host
cells. Molecules. 18:9550–9566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berman E, Heller G, Santorsa J, McKenzie
S, Gee T, Kempin S, Gulati S, Andreeff M, Kolitz J, Gabrilove J, et
al: Results of a randomized trial comparing idarubicin and cytosine
arabinoside with daunorubicin and cytosine arabinoside in adult
patients with newly diagnosed acute myelogenous leukemia. Blood.
77:1666–1674. 1991.PubMed/NCBI
|
|
23
|
Pulte D, Gondos A and Brenner H: Expected
long-term survival of patients diagnosed with acute myeloblastic
leukemia during 2006–2010. Ann Oncol. 21:335–341. 2010. View Article : Google Scholar
|
|
24
|
Vargas JR, Stanzl EG, Teng NN and Wender
PA: Cell-penetrating, guanidinium-rich molecular transporters for
overcoming efflux-mediated multidrug resistance. Mol Pharm.
11:2553–2565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nori A and Kopecek J: Intracellular
targeting of polymer-bound drugs for cancer chemotherapy. Adv Drug
Deliv Rev. 57:609–636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng Q, Wu H, Yu Q, Kim DH, Lipton JH,
Angelini S, Soverini S, Vivona D, Takahashi N and Cao J: ABCB1
polymorphisms predict imatinib response in chronic myeloid leukemia
patients: A systematic review and meta-analysis. Pharmacogenomics
J. 15:127–134. 2015. View Article : Google Scholar
|
|
27
|
Kosztyu P, Bukvova R, Dolezel P and
Mlejnek P: Resistance to daunorubicin, imatinib, or nilotinib
depends on expression levels of ABCB1 and ABCG2 in human leukemia
cells. Chem Biol Interact. 219:203–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shaffer BC, Gillet JP, Patel C, Baer MR,
Bates SE and Gottesman MM: Drug resistance: Still a daunting
challenge to the successful treatment of AML. Drug Resist Updat.
15:62–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krishna R, St-Louis M and Mayer LD:
Increased intracellular drug accumulation and complete
chemosensitization achieved in multidrug-resistant solid tumors by
co-administering valspodar (PSC 833) with sterically stabilized
liposomal doxorubicin. Int J Cancer. 85:131–141. 2000. View Article : Google Scholar
|
|
30
|
Golianu B, Krane EJ, Galloway KS and
Yaster M: Pediatric acute pain management. Pediatr Clin North Am.
47:559–587. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Osipova NA, Petrova VV, Novikov GA, Ziai
GR and Mel’nikova ZL: Synthetic analgesic moradol at various stages
of surgical treatment of patients with cancer. Anesteziol
Reanimatol. 2:56–58. 1990.In Russian.
|
|
32
|
Nakadate H, Endoh M, Satake A, Sida S,
Hatayama Y, Hatae Y, Takeda T, Wada I, Itho T and Kidoguchi T:
Continuous infusion of butorphanol for pain in children with
cancer. Gan To Kagaku Ryoho. 16:3495–3498. 1989.In Japanese.
PubMed/NCBI
|
|
33
|
Shi Z, Tiwari AK, Shukla S, Robey RW,
Singh S, Kim IW, Bates SE, Peng X, Abraham I, Ambudkar SV, et al:
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug
resistance. Cancer Res. 71:3029–3041. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sodani K, Patel A, Anreddy N, Singh S,
Yang DH, Kathawala RJ, Kumar P, Talele TT and Chen ZS: Telatinib
reverses chemotherapeutic multidrug resistance mediated by ABCG2
efflux transporter in vitro and in vivo. Biochem Pharmacol.
89:52–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang XK, To KK, Huang LY, Xu JH, Yang K,
Wang F, Huang ZC, Ye S and Fu LW: Afatinib circumvents multidrug
resistance via dually inhibiting ATP binding cassette subfamily G
member 2 in vitro and in vivo. Oncotarget. 5:11971–11985.
2014.PubMed/NCBI
|
|
36
|
Wang YJ, Kathawala RJ, Zhang YK, Patel A,
Kumar P, Shukla S, Fung KL, Ambudkar SV, Talele TT and Chen ZS:
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes
multidrug resistance by inhibiting the efflux activity of the
ABCB1. Biochem Pharmacol. 90:367–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang H, Wang YJ, Zhang YK, Wang DS,
Kathawala RJ, Patel A, Talele TT, Chen ZS and Fu LW: AST1306, a
potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G
member 2-mediated multidrug resistance. Cancer Lett. 350:61–68.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang D, Kathawala RJ, Chufan EE, Patel A,
Ambudkar SV, Chen ZS and Chen X: Tivozanib reverses multidrug
resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP).
Future Oncol. 10:1827–1841. 2014. View Article : Google Scholar
|
|
39
|
Hamabe W, Maeda T, Fukazawa Y, Kumamoto K,
Shang LQ, Yamamoto A, Yamamoto C, Tokuyama S and Kishioka S:
P-glycoprotein ATPase activating effect of opioid analgesics and
their P-glycoprotein-dependent antinociception in mice. Pharmacol
Biochem Behav. 85:629–636. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gonzalez LG, Masocha W, Sánchez-Fernández
C, Agil A, Ocaña M, Del Pozo E and Baeyens JM: Changes in
morphine-induced activation of cerebral Na+,
K+-ATPase during morphine tolerance: Biochemical and
behavioral consequences. Biochem Pharmacol. 83:1572–1581. 2012.
View Article : Google Scholar : PubMed/NCBI
|
